Медицинская литература. Новинки

 

 

 

 

 

 

Диагностика и лечение гастринпродуцирующих опухолей и синдрома Золлингера-Эллисона

Вы можете загрузить полный текст статьи в формате pdf

Ключевые слова:

Литература:
1. Akerstrom G., Hessman O., Hellman P., Skogseid B. Pancreatic
tumours as part of the MEN-1 syndrome // Best Pract. Res.
Clin. Gastroenterol. 2005. V. 19. P. 819–830.
2. Alexander H.R., Bartlett D.L., Venson D.J. et al. Analysis of factors assosiated with long-term (five or more years ) cure in
patients undergoing operation for ZollingerEllison syndrome //
Surgery. 1998. V. 124. P. 1160–1169.
3. Anlanf M., Perren A., Meyer C.L., Schmid S. et al. Precursor lesions in patients with multiple endocrine neoplasia type 1-associated duodenal gastrinomas // Gastroenterology. 2005. V. 128.
P. 1187–1198.
4. Anthony L.B., Woltering E.A., Espenan G. et al. Indium III –pentetreotide prolongs survival in gastroenteropancreatic malignancies // Semin. Med. 2002. V. 32. P. 123–132.
5. Arnold R., Rinke A., Schmidt C., Hofbauer L. Chemotherapy //
Best Pract. Res. Clin. Gastroenterol. 2005. V. 19. P. 649–656.
6. Corleto V.D., Annibale B., Gibril F., Angeletti S. et al. Does the
widespread use of proton pump inhibitors mask, complicate
and/or delay the diagnosis of ZollingerEllison syndrome? //
Aliment. Pharmacol. Ther. 2001. V. 15. P. 1555–1561.
7. Damanini F., Gibrill J.C., Reynolds J.L. et al. Value of somatostatin receptor scintigraphy: a prospective study in gastrinoma of
its effect on clinical management // Gastroenterology. 1997.
V. 112. P. 335–341.
8. Faiss S., Pape U.F., Bohmig M. et al. Prospective, randomized,
multicenter trial on the antiproliferative effect of lanreotide, interferonalfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors – The International
Lanreotide and Interferon Alfa Study Group // J. Clin. Oncol.
2003. V. 21. P. 2689–2696.
9. Farley D.R., van Heerden J., Grant C.S., et al. The Zollinger –
Ellison syndrome: A collective surgical experience // Ann. Surg.
1991. V. 215. P. 561–569.
10. Frucht H., Norton J.A., London J.F., Vinayek R. et al. Detection
of duodenal gastrinomas by operative endoscopic transillumination: a prospective study // Gastroenterology. 1990. V. 99.
P. 1622–1627.
11. Gibril F., Reynolds J.C., Doppman J.L., Chen C.C. et al.
Somatostatin receptor scintigraphy: its sensitivity compared with
that of other imaging methods in detecting primary and metastatic gastrinomas: a prospective study // Ann. Intern. Med. 1996.
V. 125. P. 26–34.
12. Gibril F., Jensen R.T. Diagnostic uses of radiolabelled somatostatinreceptor analogues in gastroenteropancreatic endocrine
tumors // Dig. Liver. Dis. 2004. V.36. P. 106–120.
13. Gibril F., Jensen R.T. ZollingerEllison syndrome revisited:
diagnosis, biologic markers, associated inherited disorders, and
acid hypersecretion // Curr Gastroenterol. Rep. 2004. V. 6.
P. 454–463.
14. Gibril F., Schumann M., Pace A., Jensen R.T. Multiple endocrine
neoplasia type 1 and ZollingerEllison syndrome: a prospective
study of 107 cases and comparison with 1009 patients from the
literature // Medicine. 2004. V. 83. P. 43–83.
15. Jensen R.T. Zolliger–Ellison syndrome; in Doherty G M,
Skogseid B (eds): Surgical Endocinology: Сlinical Sindromes.
Philadelphia: Lippincott Williams, 2001. P. 291–344.
16. Jensen R.T. Gastrinomas: advances in diagnosis and management // Neuroendocrinology. 2004. V. 80. P. 23–27.
17. Jensen R., Niederle B., Mitry E., Ramage J.K. Gastrinoma (duodenal and pancreatic) // Neuroendocrinology. 2006. V. 84.
P. 173–182.
18. Imamura M., Takahashi K. Use of selective arterial secretin
injection test to guide surgery in patients with Zollinger–Ellison
syndrome // World J. Surg. 1993. V. 17. P. 433–439.
19. Komminoth P., Perren A., Oberg K., Rindi G. et al. Gastrinoma. In
DeLellis R.A., Lloyd R., Heitz P.U., Eng С. (eds). Pathology
and Genetics: Tumors of the Endocrine Organs. WHO
Classification of Tumors. Lyon: IARC Press, 2004. P. 191–194.
20. Langer P., Kann P.H., Fendrich V. et al. Prospective Evaluation
of Imaging Procedures for the Detection of Pancreaticoduodenal
Endocrine Tumors in Patients with Multiple Endocrine
Neoplasia Type 1 // World J. Surg. 2004. V. 28. P. 1317–1322.
21. Leong W.L., Pasieka J.L. Regression of metastatic carcinoid
tumors with octreotide therapy: Two case reports and a review of
the literature // J. Surg. Oncol. 2002. V. 79. P. I80–187.
22. Maton P.N., Miller D.L., Doppman J.L., Collen M.J. et al. Role of
selective angiography in the management of Zollinger–Ellison
syndrome // Gastroenterology. 1987. V. 92. P. 913–918.
23. Mignon M., Cadiot G. Diagnostic and therapeutic criteria in
patients wilh ZollingerEllison syndrome and multiple
endocrine neoplasia type 1 // J. Intern. Med. 1998. V. 243.
P. 489–494.
24. Norton J.A., Doherty G.M., Fraker D.L. Surgical treatment of
localized gastrinoma within the liver: a prospective study // Surg.
1998. V. 124. P. 1145–1152.
25. Norton J.A., Alexander H.R., Fraker D.L., Venzоn D.J. et al.
Comparison of surgical results in patients with advanced and
limited disease with multiple endocrine neoplasia type 1 and
Zollinger–Ellison syndrome // Ann. Surg. 2001. V. 234.
P. 495–506.
26. Norton J.A., Alexander H.R., Fraker D.L. et al. Does the use of
routine duodenotomy (DUODX) affect rate of cure, development
of liver metastases or survival in patients with Zollinger–Ellison
syndrome (ZES)? // Ann. Surg. 2004. V. 239. P. 617–626.
27. Norton J.A., Jensen R.T. Resolved and unresolved controversies
in the surgical management of patients wilh Zollinger–Ellison
syndrome // Ann. Surg. 2004. V. 240. P. 757–773.
28. Pereira P.L., Wiskirchen J. Morphological and functional investigations of neuroendocrine tumors of the pancreas // Eur
Radiol. 2003. V. 13. P. 2133–2146.
29. Plockinger U., Rindi G., Arnold R., Eriksson B. et al. Guidelines
for the diagnosis and treatment of neuroendocrine gastrointestinal tumours // Neuroendocrinology. 2004. V. 80. P. 394–424.
30. Roche A., Girish B.V., de Baere T. et al. Trans-catheter arterial
chemoembolization as first – line treatment for hepatic metastases from endocrine tumors // Eur Radiol. 2003. V. 13.
P. 136–140.
31. Roy P.K., Venzon D.J., Shojamanesh H. et al. Zollinger–Ellison
syndrome. Clinical presentation in 261 patients // Medicine
(Baltimore). 2000 . V. 79(6). P. 379–411.
32. Roy P., Venzon D.J., Feigenbaum K.M., Koviack P.D. et al.
Gastric secretion in ZollingerEllison syndrome: correlation with
clinical expression, tumor extent and role in diagnosis. A prospective NIH study of 235 patients and review of the literature in 984
cases // Medicine (Baltimore). 2001. V. 80. P. 189–222.
33. Sarmiento J.M., Que F.G. Hepatic surgery for metastases from
neuroendocrine tumors // Surg. Oncol. Clin. N. Am. 2003. V.
12. P. 231–242.
34. Shojamanesh H., Gibril F., Louie A., Ojeaburu J.V. et al. Prospective study of the antitumor efficacy of long-term octreotide
treatment in patients with progressive metastatic gastrinomas //
Cancer. 2002. V. 94. P. 331–343.
35. Termanmi B., Gibril F., Reynolds J.C. et al. Value of somatostatin
receptor scintigraphy: a prospective study in gastrinoma of its
effect on clinical management // Gastroenterology. 1997. V. 112.
P. 335–347.
36. Thompson N.W. Management of pancreatic endocrine tumors in
patients with multiple endocrine neoplasia type 1 // Surg. Oncol.
Clin. N. Amer. 1998. V. 7. P. 881–888.
37. Tomassetti M., Migliori M., Corinaldesi R. Gullo L. Treatment of
gastroenteropancreatic neuroendocrine tumours with octreotide
LAR // Aliment. Pharmacol. Ther. 2000. V. 14. P. 557–560.
38. Van Hoe L., Gryspeerdt S., Marchal G. et al. Helical CT for the
preoperative localization of islet cells tumors of the pancreas:
Value of arterial and parenchymal phase images // Am. J. Radiol.
1995. V. 165. P. 1437–1445.
39. Veldhus J.D., Norton J.A., Wells S.A. Surgical versus medical
treatment of multiple endocrine neoplasia ( MEN ) type 1 //
J. Clin. Endocrinol. Metab. 1997. V. 82. P. 357–365.
40. Weber H.C., Venzon D.J., Lin J.T. et al. Determinants of
metastatic rale and survival in patients with Zollinger–Ellison
syndrome: a prospective long-term study // Gastroenterology.
1995. V. 108. P. 1637–1649.

Keywords: